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Abstract: Fungi associated with the marine sponge Tethya aurantium were isolated and 
identified by morphological criteria and phylogenetic analyses based on internal 
transcribed spacer (ITS) regions. They were evaluated with regard to their secondary 
metabolite profiles. Among the 81 isolates which were characterized, members of 
21 genera were identified. Some genera like Acremonium, Aspergillus, Fusarium, 
Penicillium, Phoma, and Trichoderma are quite common, but we also isolated strains 
belonging to genera like Botryosphaeria, Epicoccum, Parasphaeosphaeria, and 
Tritirachium which have rarely been reported from sponges. Members affiliated to the 
genera Bartalinia and Volutella as well as to a presumably new Phoma species were first 
isolated from a sponge in this study. On the basis of their classification, strains were 
selected for analysis of their ability to produce natural products. In addition to a number of 
known compounds, several new natural products were identified. The scopularides and 
sorbifuranones have been described elsewhere. We have isolated four additional substances 
which have not been described so far. The new metabolite cillifuranone (1) was isolated 
from Penicillium chrysogenum strain LF066. The structure of cillifuranone (1) was 
elucidated based on 1D and 2D NMR analysis and turned out to be a previously postulated 
intermediate in sorbifuranone biosynthesis. Only minor antibiotic bioactivities of this 
compound were found so far. 
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1. Introduction 
Natural products are of considerable importance in the discovery of new therapeutic agents [1]. 
Apart from plants, bacteria and fungi are the most important producers of such compounds [2]. For a 
long time neglected as a group of producers of natural products, marine microorganisms have more 
recently been isolated from a variety of marine habitats such as sea water, sediments, algae and 
different animals to discover new natural products [3,4]. In particular, sponges which are filter feeders 
and accumulate high numbers of microorganisms have attracted attention [5,6]. Though the focus of 
most of these investigations was concerned with the bacteria, a series of investigations identified 
marine sponges also as a good source of fungi [7–18]. Due to the accumulation of microorganisms, it 
is no surprise that sponges account for the majority of fungal species isolated from the marine realm [19]. 
However, the type of association and a presumable ecological function of accumulated fungi in 
sponges remain unclear and little evidence is available on fungi specifically adapted to live within 
sponges. One example is represented by fungi of the genus Koralionastes, which are known to form 
fruiting bodies only in close association with crustaceous sponges associated with corals [20]. 
Consistently, fungi isolated from sponges account for the highest number (28%) of novel 
compounds reported from marine isolates of fungi [19]. Marine isolates of fungi evidently are a rich 
source of chemically diverse natural products which has not been consequently exploited so far. 
Among a number of metabolites from sponge-associated fungi with promising biological activities are 
the cytotoxic gymnastatins and the p56
lck
 tyrosine kinase inhibitor ulocladol [21,11]. In view of these 
exciting data and our own previous work on the bacterial community associated with  
Tethya aurantium [22], we have now isolated and identified a larger number of fungi from this sponge. 
In European waters, Tethya aurantium is commonly found in the Atlantic Ocean, the English Channel, 
the North Sea as well as the Mediterranean Sea, where our specimens originated from [23]. Except for 
a single report from Indriani [24], fungi associated with Tethya sp. have not been investigated so far. 
The formation of natural products by these fungi and their biotechnological potential has not been 
evaluated yet.  
For the identification of the fungal isolates from Tethya aurantium, we combined morphological 
criteria and phylogenetic analyses based on the sequence of the internal transcribed spacer (ITS) 
regions 1 and 2. On the basis of their classification, strains were selected for analysis of their ability to 
produce natural products. In addition to a number of known compounds, the new cyclodepsipeptides 
scopularide A and B were produced by a Scopulariopsis brevicaulis isolate [25]. Because of their 
antiproliferative activities against several tumor cell lines, these peptides and their activities have been 
patented [26]. During the present study, we have isolated four so far undescribed substances. Structure 
and properties of the new cillifuranone, a secondary metabolite from Penicillium chrysogenum strain 
LF066 are reported here. 
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2. Results and Discussion 
2.1. Identification of the Fungal Strains Isolated from T. aurantium 
In most studies on fungi associated with sponges the taxonomic classification of the fungi was 
based exclusively on morphological characteristics and in many cases identification was possible only 
at the genus level [17]. This can be attributed to the fact that taxonomic identification of fungi at the 
species level is not always easy. It is impaired by the fact that under laboratory conditions many fungi 
do not express reproductive features like conidia or ascomata, which represent important traits for 
identification. These fungi are classified as “mycelia sterilia”.  
Therefore, morphological criteria as well as sequence information and the determination  
of phylogenetic relationships are considered to be necessary for the identification of fungi.  
Consequently, we have combined the morphological characterization with a PCR-based analysis using  
ITS1-5.8S-rRNA-ITS2 gene sequences to identify 81 fungi isolated from Tethya aurantium. Based on 
these criteria the strains could be identified to the species level (Figure 1, Table 1).  
Figure 1. Scanning electron micrographs of Fusarium sp. strain LF236. (A) Multicellular, 
curved conidiospore; (B) Exudates in the surface layer of a liquid culture; (C) Intercalary 
chlamydospores in the mycelium. 
   
(A)    (B)    (C) 
Table 1. Identification of fungal strains isolated from Tethya aurantium samples based on 
morphological criteria as well as genetic analysis of the internal transcribed spacer (ITS) 
region. Closest relatives to fungal strains according to BLAST search are presented. In case 
BLAST search yielded a cultured but undesignated strain as closest relative, the closest 
cultured and the designated relative is given additionally. 
Strain 
Morphological 
identification 
Seq. length 
(nt) 
Next related cultivated strain (BLAST) Acc. No. 
Similarity  
(%) 
Overlap 
(nt) 
LF063 Cladosporium sp. 483 
Fungal sp. ARIZ AZ0920 
Cladosporium sphaerospermum isolate KH00280 
HM123596.1  
GU017501.1 
99 
99 
482 
482 
LF064 
Scopulariopsis 
murina 
473 
Ascomycota sp. 840  
Phialemonium obovatum strain CBS 279.76 
GU934604.1 
AB278187.1 
92 
89 
360 
340 
LF065 Penicillium sp. 546 Penicillium glabrum strain 4AC2K GU372904.1 99 545 
LF066 Penicillium sp. 551 Penicillium chrysogenum strain JCM 22826 AB479305.1 99 549 
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Table 1. Cont. 
LF073 Aspergillus sp. 533 Aspergillus versicolor isolate UOA/HCPF 8709 FJ878627.1 100 532 
LF177 Alternaria sp. 568 Lewia infectoria strain IA310 AY154718 99 561 
LF178 Cladosporium sp. 479 
Fungal endophyte sp. g6 
Cladosporium cladosporioides strain CC1 
HM537022.1 
HM210839.1 
100 
100 
479 
479 
LF179 Mycelia sterilia 559 
Fungal endophyte isolate 9137 
Paraphaeosphaeria sp. LF6 
EF419991.1 
GU985234.1 
100 
99 
555 
557 
LF183 Cladosporium sp. 523 
Dothideomycetes sp. 11366 
Cladosporium cladosporioides isolate SLP001 
GQ153254.1 
FJ932747.1 
99 
99 
522 
521 
LF184 Cladosporium sp. 475 
Fungal endophyte sp. g6 
Cladosporium cladosporioides strain CC1 
HM537022.1 
HM210839.1 
100 
100 
475 
475 
LF236 Fusarium sp. 512 
Fusarium sp. CPK3469 
Gibberella intricans strain ATCC MYA-3861 
FJ827615.1 
GU291255.1 
99 
99 
511 
511 
LF237 Fusarium sp. 503 
Fusarium sp. CPK3337 
Fusarium equiseti strain NRRL 36478 
FJ827616.1 
GQ505743.1 
100 
100 
503 
503 
LF238 Fusarium sp. 513 
Fusarium sp. CPK3469 
Fusarium equiseti strain NRRL 36478 
FJ827615.1 
GQ505743.1 
100 
100 
513 
513 
LF239 Fusarium sp. 509 
Fusarium sp. NRRL 45997 
Fusarium equiseti strain NRRL 36478 
GQ505761.1 
GQ505743.1 
99 
99 
503 
503 
LF240 Mycelia sterilia 528 
Lewia sp. B32C 
Lewia infectoria strain IA241 
EF432279.1 
AY154692.1 
99 
99 
525 
525 
LF241 Mycelia sterilia 513 
Botryosphaeria sp. GU071005 
Sphaeropsis sapinea strain CBS109943 
AB472081.1 
DQ458898.1 
100 
100 
512 
512 
LF242 Penicillium sp. 538 Penicillium brevicompactum isolate H66s1 EF634441.1 99 537 
LF243 Penicillium sp. 532 Penicillium virgatum strain IHB F 536 HM461858.1 100 530 
LF244 Cladosporium sp. 516 
Fungal endophyte sp. g2 
Davidiella tassiana strain BLE25 
HM537019.1 
FN868485.1 
99 
99 
516 
516 
LF245 Fusarium sp. 494 
Fusarium sp. CPK3514 
Fusarium equiseti strain NRRL 13402 
FJ840530.1 
GQ505681.1 
100 
100 
494 
494 
LF246 Volutella sp. 548 Volutella ciliata strain BBA 70047 AJ301966.1 99 547 
LF247 Fusarium sp. 520 
Fusarium sp. LD-135 
Fusarium equiseti strain NRRL 13402 
EU336989.1 
GQ505681.1 
99 
99 
509 
504 
LF248 Botrytis sp. 504 
Fungal endophyte sp. g18 
Botryotinia fuckeliana strain OnionBC-1 
HM537028.1 
FJ169667.2 
100 
100 
504 
504 
LF249 Penicillium sp. 552 
Penicillium sp. BM 
Penicillium commune isolate HF1 
GU566211.1 
GU183165.1 
99 
99 
551 
551 
LF250 Penicillium sp. 564 Penicillium chrysogenum strain ACBF 003-2 GQ241341.1 97 547 
LF251 Penicillium sp. 550 
Penicillium sp. F6 
Penicillium chrysogenum strain ACBF 003-2 
GU566250.1 
GQ241341.1 
100 
100 
550 
550 
LF252 Fusarium sp. 513 
Fusarium sp. NRRL 45997 
Fusarium equiseti strain NRRL 36478 
GQ505761.1 
GQ505743.1 
99 
99 
511 
511 
LF253 Trichoderma sp. 543 Hypocrea lixii strain OY3207 FJ571487.1 100 540 
LF254 Clonostachys sp. 525 Bionectria ochroleuca strain G11 GU566253.1 100 524 
LF255 Alternaria sp. 518 
Fungal endophyte sp. g76 
Alternaria alternata strain 786949 
HM537053.1 
GU594741.1 
100 
100 
518 
518 
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LF256 Botrytis sp. 535 Beauveria bassiana strain G61 GU566276.1 99 533 
LF257 Cladosporium sp. 495 Davidiella tassiana strain G20 GU566258.1 100 495 
LF258 Phoma sp. nov. 538 
Fungal sp. GFI 146 
Septoria arundinacea isolate BJDC06 
AJ608980.1 
GU361965.1 
93 
91 
470 
460 
LF259 Penicillium sp. 522 Penicillium brevicompactum strain: JCM 22849 AB479306.1 100 522 
LF260 Sphaeropsidales 508 Pyrenochaeta cava isolate olrim63 AY354263.1 100 508 
LF491 Aspergillus sp. 555 Petromyces alliaceus isolate NRRL 4181 EF661556.1 99 555 
LF494 Fusarium sp. 469 Fusarium sp. CB-3 GU932675.1 100 469 
LF496 Mycelia sterilia 531 Verticillium sp. TF17TTW FJ948142.1 99 529 
LF501 Aspergillus sp. 514 Aspergillus granulosus isolate NRRL 1932 EF652430.1 100 514 
LF508 Not identified 501 Phoma sp. W21 GU045305.1 99 497 
LF509 Fusarium sp. 504 Fusarium sp. CPK3514 FJ840530.1 99 503 
LF510 Fusarium sp. 516 Fusarium sp. FL-2010c isolate UASWS0396 HQ166535.1 99 514 
LF514 Trichoderma sp. 546 Trichoderma sp. TM9 AB369508.1 100 546 
LF526 Eurotium sp. 486 
Eurotium sp. FZ 
Eurotium chevalieri isolate UPM A11 
HQ148160.1 
HM152566.1 
100 
100 
486 
486 
LF530 Alternaria sp. 522 Alternaria sp. 7 HF-2010 HQ380788.1 100 522 
LF534 Penicillium sp. 540 Penicillium roseopurpureum strain E2 GU566239.1 99 536 
LF535 Acremonium sp. 525 
Acremonium sp. FSU2858 
Lecanicillium lecanii strain V56 
AY633563.1 
DQ007047.1 
99 
99 
523 
510 
LF537 Cladosporium sp. 503 Cladosporium cladosporioides strain F12 HQ380766.1 100 503 
LF538 Mucor hiernalis 598 Mucor hiemalis isolate UASWS0442 HQ166553.1 100 598 
LF540 Not identified 578 Hypocrea lixii isolate FZ1302 HQ259308.1 99 575 
LF542 Mycelia sterilia 458 
Peyronellaea glomerata isolate NMG_27 
Phoma pomorum var. pomorum strain CBS 
539.66 
HM776432  
FJ427056.1 
99 
99 
457 
457 
LF543 Alternaria sp. 522 Alternaria citri strain IA265 AY154705.1 100 522 
LF547 Aspergillus sp. 539 Aspergillus minutus isolate NRRL 4876 EF652481.1 98 529 
LF550 Mycelia sterilia 524 
Bartalinia robillardoides CBS:122686 
Ellurema sp. 42-3 
EU552102.1 
AY148442.1 
99 
99 
522 
514 
LF552 
Epicoccum 
nigrum 
506 Epicoccum nigrum strain GrS7 FJ904918.1 99 503 
LF553 Aspergillus sp. 528 Aspergillus sp. Da91 HM991178.1 100 528 
LF554 Aspergillus sp. 525 Aspergillus sp. Da91 HM991178.1 100 525 
LF557 Mycelia sterilia 528 
Fusarium sp. FL-2010f 
Fusarium oxysporum strain TS08-137-1-1 
HQ166539.1 
AB470850.1 
99 
 
522 
 
LF558 Not identified 498 Phoma sp. W21 GU045305.1 100 498 
LF562 Tritirachium sp. 504 Tritirachium sp. F13 EU497949.1 99 498 
LF563 Trichoderma sp. 537 Hypocrea lixii isolate DLEN2008014 HQ149778.1 100 537 
LF576 Clonostachys sp. 504 Bionectria cf. ochroleuca CBS 113336 EU552110.1 99 503 
LF577 Penicillium sp. 538 Penicillium brevicompactum isolate NMG_25 HM776430.1 99 534 
LF580 * 
Scopulariopsis 
brevicaulis 
916 Scopulariopsis brevicaulis strain NCPF 2177 AY083220.1 99 686 
LF581 Fusarium sp. 504 Fusarium sp. NRRL 45996 GQ505760.1 99 502 
Mar. Drugs 2011, 9  
 
 
566 
Table 1. Cont. 
LF584 Aspergillus sp. 543 Aspergillus sp. N13 GQ169453.1 99 542 
LF590 Penicillium sp. 522 Penicillium citreonigrum strain Gr155 FJ904848.1 100 522 
LF592 Paecilomyces sp. 544 
Fungal endophyte sp. P1201A 
Paecilomyces lilacinus strain CG 271 
EU977225.1 
EU553303.1 
99 
98 
541 
516 
LF594 Mycelia sterilia 531 
Fusarium sp. FL-2010c 
Fusarium acuminatum strain NRRL 54217 
HQ166535.1 
HM068325.1 
99 
99 
527 
527 
LF596 Penicillium sp. 529 
Penicillium sp. FF24 
Penicillium canescens strain QLF83 
FJ379805.1 
FJ025212.1 
100 
100 
529 
529 
LF607 Penicillium sp. 532 
Penicillium sp. 17-M-1 
Penicillium sclerotiorum strain SK6RN3M 
EU076929.1 
EU807940.1 
99 
99 
523 
520 
LF608 Cladosporium sp. 495 
Fungal sp. mh2981.6 
Cladosporium cladosporioides strain CC1 
GQ996077.1  
HM210839.1 
100 
100 
495 
495 
LF610 Clonostachys sp. 528 
Fungal sp. mh2053.3 
Bionectria ochroleuca isolate Rd0801 
GQ996069.1 
HQ115728.1 
99 
99 
524 
524 
LF626 Mycelia sterilia 588 Trichoderma cerinum isolate C.P.K. 3619 GU111565.1 99 586 
LF627 Aspergillus sp. 509 Aspergillus sp. 4-1 HQ316558.1 100 509 
LF629 Mycelia sterilia 510 Cladosporium cladosporioides strain F12 HQ380766.1 99 509 
LF630 Penicillium sp. 518 Penicillium brevicompactum isolate H66s1 EF634441.1 100 518 
LF631 Epicoccum nigrum 514 Epicoccum nigrum strain AZ-1 DQ981396.1 99 512 
LF634 Aspergillus sp. 581 Aspergillus terreus isolate UOA/HCPF 10213 GQ461911.1 99 579 
LF644 Clonostachys sp 528 Bionectria rossmaniae strain CBS 211.93 AF210665.1 99 521 
LF646 Mycelia sterilia 510 Cladosporium cladosporioides strain F12 HQ380766.1 99 509 
A = anamorph; T = teleomorph; Alternaria (A) = Lewia (T); Aspergillus (A) = Petromyces (T) and Eurotium (T);  
Beauveria (A) = Cordyceps (T); Botrytis (A) = Botryotinia (T); Cladosporium (A) = Davidiella (T);  
Fusarium (A) = Gibberella (T); Clonostachys (A) = Bionectria (T); Trichoderma (A) = Hypocrea (T);  
Phoma = Pleurophoma (synonym); nt = nucleotides; * phylogenetic data to LF580 are derived from the 18S rRNA 
gene sequence.  
First of all, morphological criteria enabled the identification of most of the fungal isolates at the 
genus level (Table 1). However, under the culture conditions applied, 11 strains did not produce spores 
and were designed as “mycelia sterilia”. A morphological classification of these strains was not 
possible. Despite the formation of spores, another four strains could not be classified on the basis of 
morphological characteristics. 
In order to verify the results of the morphological examination and identify the strains at the species 
level, they were subjected to ITS1-5.8S-ITS2 gene sequence analysis. The results obtained from this 
sequence analysis corresponded well with those from the morphological identification (Table 1, 
Figure 2) and in addition allowed identification of those strains not identified microscopically. In most 
cases, the sequence data and the phylogenetic relationships allowed the identification at the species 
level. Results from BLAST search are depicted in Table 1. Taking together morphological and genetic 
characteristics, most isolates belong to the Ascomycotina with representatives of the fungal classes 
Dothideomycetes (24 isolates), Eurotiomycetes, (25 isolates), Sordariomycetes (30 isolates) and 
Leotiomycetes (1 isolate). Only a single isolate (strain LF538) was classified as belonging to  
the Mucoromycotina.  
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Figure 2. Phylogenetic consensus tree based on ITS1-5.8S-ITS2 gene sequences calculated 
by Bayesian inference assuming the general time reversible (GTR) model (6 substitution 
rate parameters, gamma-shaped rate variation, proportion of invariable sites). Isolates from 
Tethya aurantium obtained during this study are printed in bold. Numbers on nodes 
indicate Bayesian posterior probability values. nt = nucleotides. 
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AJ300335 Cladosporium cladosporioides strain CBS 169.54
96
GU017501 Cladosporium sphaerospermum isolate KH00280
LF063
98
100
100
FJ427056 Phoma pomorum var. pomorum strain CBS 539.66
LF542
HM776432 Peyronellea glomerata isolate NMG 27
FJ427057 Phoma pomorum var. pomorum strain PD 81/592
82
LF552
LF631
DQ981396 Epicoccum nigrum strain AZ-1
LF508
LF558
GU062248 Pyrenochaeta cava isolate I170
LF260
100
99
LF258
AJ608980 Fungal sp. GFI 146
95
FJ426987 Phoma chrysantemicola strain PD 92/468
AJ496632 Phaeosphaeria pontiformis strain CBS 589.86
79
100
98
LF177
AY154695 Alternaria triticina strain IA245
98
AY762947 Alternaria oregonensis strain EGS 29-194
86
AM176663 Lewia infectoria clone (23)5
LF240
FM958526 Alternaria infectoria strain CBS 210.86
AY762946 Alternaria metachromatica strain EGS 38-132
AY154705 Alternaria citri strain IA265
LF530
LF543
GU594741 Alternaria alternata strain 786949
LF255100
100
100
AY642531 Paraconiothyrium brasiliense strain CBS 100299
LF179
GU985234 Paraphaeosphaeria sp. LF6
100
EF094552 Microsphaeropsis arundinis strain 04-359-2614
100
100
97
AB472081Botryosphaeria sp. GU071005
DQ458898 Sphaeropsis sapinea strain CBS 109943 
LF241
100
FJ433878 Saccharomyces boulardii
strain UOA/HCPF EM 10049
100
100
100
100
100
1
0
0
1
0
0
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As shown in the phylogenetic tree (Figure 2), 10 isolates of the Dothideomycetes closely affiliated 
to fungal species of the order Capnodiales (Cladosporium spp. and its teleomorph Davidiella). Within 
the order Pleosporales (13 isolates) 5 isolates were closely related to Alternaria sp., including  
Lewia infectoria as teleomorph. From the same order we also isolated 2 strains of the species 
Epicoccum nigrum and 1 Paraphaeosphaeria strain. Furthermore, 5 isolates of the genus Phoma were 
found, of which one isolate (strain LF258) shows only 91% sequence similarity to  
Septoria arundinacea as next relative according to BLAST results (Table 1) and presumably represents 
a new species in the Phoma lineage. The low similarity of this isolate to known sequences is also 
reflected in the position in the phylogenetic tree, clustering distinct from other Phoma species. A single 
isolate (strain LF241) was assigned to Sphaeropsis sapinea/Botryosphaeria sp. within the order 
Botryosphaeriales in the class Dothideomycetes. 
All 25 isolates assigned to the class Eurotiomycetes were affiliated to the order Eurotiales and are 
represented by 14 isolates closely affiliating to Penicillium species (P. glabrum, P. virgatum/ 
P. brevicompactum, P. griseofulvum/P. commune, P. chrysogenum, P. sclerotiorum/P. citreonigrum, 
P. citreoviride/P. roseopurpureum, P. canescens), 10 representatives of the genus Aspergillus 
(including 2 of its teleomorphs, Petromyces alliaceus and Eurotium chevalieri) and 1 isolate  
of Paecilomyces.  
The 30 isolates affiliated to the class Sordariomycetes were grouped into the orders Hypocreales  
(26 isolates), Microascales (2 isolates) and Xylariales (1 isolate). Within the Hypocreales, one isolate 
each was closely related to Beauveria bassiana (strain LF256), Tritirachium album (strain LF562), 
Verticillium sp. (strain LF496), and Volutella ciliata (strain LF246). The most frequent genera within 
this order were Fusarium (13 isolates), Trichoderma (5 isolates, including Hypocrea teleomorphs) and 
Clonostachys (4 isolates, including teleomorphs of Bionectria). The Microascales were represented by 
two isolates of the genus Scopulariopsis. One of these (strain LF064), morphologically classified as 
Scopulariopsis murina, was distantly related to the next cultured relative (89% according to BLAST 
search) and appears as a sister group to the Scopulariopsis lineage in the phylogenetic tree. The order 
Xylariales was represented by only a single isolate (strain LF550), Bartalinia robillardoides. As the 
only representatives of the order Helotiales within the class Leotiomycetes strain LF248 was closely 
related to Botryotinia fuckeliana. 
The combination of microscopic and genetic analyses has proven to be a reliable method for the 
identification of fungal isolates and results from both approaches corresponded quite well (Table 1, 
Figure 2). The reliable identification of isolates is a fundamental prerequisite in order to characterize 
the producers of marine natural products [3], to determine the occurrence of fungal species in different 
habitats, and to correlate distinct secondary metabolite patterns to fungal species. Therefore, we highly 
recommend that morphological identification of fungal isolates consequently should be verified by 
molecular means and thus raise the number of reliably identified species in public databases.  
A number of investigations, mainly with the aim of finding novel natural products, showed that 
most marine sponges harbor a plethora of cultivable fungi within their tissue [10–15,18]. Despite the 
large number of fungi isolated from sponges, a selective accumulation of specific taxa within sponges 
and a truly marine nature of these fungi is doubted, which is why they are commonly referred to as 
“marine-derived” [27,28]. In fact, it could be shown that the phylogenetic diversity of fungi isolated 
from different sponges varies [17]. It has also been stated that the taxa frequently isolated from 
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sponges resemble those described from terrestrial habitats [11,16,28]. This is in good accordance with 
our results, showing representatives of Acremonium, Aspergillus, Fusarium, Penicillium, Phoma, and 
Trichoderma to be abundant in Tethya aurantium and with those of Wang (2006) demonstrating that 
they also are widely distributed among different sponges from various locations [29]. Although it 
appears that the marine environment indeed provides various habitats for fungi, this has rarely been 
demonstrated. Nonetheless, due to the accumulation of fungi within sponges a large number of strains 
can be isolated which increases the probability to find representatives of less common taxa which 
might produce unprecedented secondary metabolites. For example, fungi belonging to the genera 
Beauveria, Botryosphaeria, Epicoccum, Tritirachium, and Paraphaeosphaeria have rarely been 
obtained from marine sponges [11,18,24] and, to the best of our knowledge, we have isolated 
Bartalinia sp. and Volutella sp. from a marine sponge for the first time.  
Although evidence is presented that some bacterial symbionts of sponges are the producers of 
metabolites originally assumed to be produced by the sponge [4], equivalent evidence for fungi is 
lacking. There is actually little evidence for sponge-specific fungal associations and the only reports on 
this matter deals with the above mentioned Koralionastes species and a yeast living in symbiosis with 
the sponge Chondrilla sp. [30]. In fact, most of the studies had the biotechnological potential of 
sponge-derived fungi in mind but not the ecological role. Our culture-dependent approach was not 
considered to approach the aspect of specificity of the association with the sponge and molecular-based 
studies would be more suited to identify specifically sponge-associated fungi. 
2.2. Secondary Metabolite Analyses 
With the cultivation-based approach used in this study, we obtained a variety of strains from a 
surprisingly broad range of phylogenetic groups of fungi. A selection of the isolated and identified 
fungi was subjected to analysis of their secondary metabolite profiles. Strains were selected in order to 
represent a wide spectrum of genera, representatives of a variety of different genera, some known to 
include strains and species known for the production of secondary metabolites others from less 
common taxa. Some of the strains selected according to systematic criteria did not produce detectable 
amounts of secondary metabolites under the applied culture conditions. Unraveling their potential of 
secondary metabolite production will require more intense studies. Those extracts which did contain at 
least one compound in significant amounts were analyzed by HPLC with DAD (UV)- and MS-detection 
and the metabolites which could be identified are listed in Table 2. A high percentage of the substances 
identified this way could be verified by 
1
H NMR spectroscopy (see Table 2). The majority of these 
metabolites have been reported from fungi before. Two of our previous reports on metabolites from 
fungi isolated from Tethya aurantium deal with the antiproliferative scopularides A–B [25,26] and the 
sorbifuranones A–C [31]. 
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Table 2. Secondary metabolites identified in extracts of fungi isolated from the sponge 
Tethya aurantium. 
Genus Strain Compound Reported from 
a
 Bioactivity 
a,b
 
Method of 
dereplication 
Alternaria LF177 
infectopyrone 
Alternaria infectoria, 
Leptosphaeria 
maculans/Phoma lingum 
 UV, MS, NMR 
phomenin A & B 
Phoma tracheiphila, 
Leptosphaeria 
maculans/Phoma lingum, 
Ercolaria funera 
phytotoxin UV, MS, NMR 
Aspergillus 
LF627 
sterigmatocystin 
Aspergillus versicolor, 
Chaetomium 
mycotoxin [32] UV, MS 
notoamid D Aspergillus sp.  UV, MS 
stephacidin A Aspergillus ochraceus cytotoxic UV, MS, NMR 
LF547 
cinereain Botrytis cinerea 
plant growth regulator, 
phytotoxin 
UV, MS, NMR 
(2′E,4′E,6′E)-6-(1′-
carboxyocta-2′,4′,6′-
trien)-9-hydroxydrim-7-
ene-11,12-olide 
Aspergillus ustus  UV, MS, NMR 
(2′E,4′E,6′E)-6-(1′-
carboxyocta-2′,4′,6′-
trien)-9-hydroxydrim-7-
ene-11-al 
Aspergillus ustus  UV, MS, NMR 
compound A 
hit in Scifinder [33], but 
no publication available 
 UV, MS, NMR 
compound B no hit in database  UV, MS, NMR 
LF553 
sydonic acid Aspergillus sydowii weakly antibacterial [34] UV, MS, NMR 
hydroxysydonic acid Aspergillus sydowii  UV, MS 
LF584 
WIN-6 6306 Aspergillus flavipes 
substance P antagonist, 
inhibition of HIV-1 
integrase [35] 
UV, MS 
aspochalasines 
Aspergillus flavipes and 
other Aspergillus sp. 
antibiotic, moderately 
cytotoxic [36] 
UV, MS, NMR 
Aspergillus/ 
Petromyces 
LF491 
isokotanin A–C 
Aspergillus alliaceus and 
Petromyces alliaceus 
moderate antiinsectan 
activities [37] 
UV, MS, NMR 
14-(N,N-Dimethyl-L-
leucinyloxy)paspalinine 
Aspergillus alliaceus 
potassium channel 
antagonist [38] 
UV, MS, NMR 
nominine or a similar 
indoloditerpene 
Aspergillus nomius, 
Aspergillus flavus, 
Petromyces alliaceus 
insecticidal properties UV, MS, NMR 
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Table 2. Cont. 
Phoma LF258 
monocerin 
Helminthosporium monoceras, 
Fusarium larvarum, 
Dreschlera ravenelii, 
Exserohilum rostratum, 
Readeriella mirabilis 
antifungal, 
insecticidal and 
phytotoxic 
properties 
UV, MS 
intermediate in the  
bio-synthesis of 
monocerin 
Dreschlera ravenelii  UV, MS, NMR 
evernin- or 
isoeverninaldehyde 
Guignardia laricina weak phytotoxin UV, MS, NMR 
Epicoccum LF552 
epicoccamide 
Epicoccum purparescens  
and other Epicoccum sp.,  
Aurelia aurita 
 UV, MS 
orevactaene Epicoccum nigrum 
binding inhibitor of 
HIV-1 rev protein to 
Rev response 
element (RRE) 
UV, MS 
Eurotium LF526 
echinulin 
Eurotium repens,  
Aspergillus amstelodami, 
Aspergillus echinulatus, 
Aspergillus glaucus 
experimentally 
hepatic and 
pulmonary effects 
UV, MS 
neoechinulines Aspergillus amstelodami 
antioxidative 
activity 
UV, MS 
auroglaucines and 
flavoglaucine 
Aspergillus and Eurotium spp. 
mycotoxin, shows 
antineo-plastic 
properties [39] 
UV, MS 
Fusarium 
LF236 equisetin 
Fusarium equiseti and 
Fusarium heterosporum 
antibacterial 
activity, inhi-bition 
of HIV-1 integrase  
UV, MS, NMR 
LF238 
equisetin 
Fusarium equiseti and 
Fusarium heterosporum 
antibacterial 
activity, inhi-bition 
of HIV-1 integrase 
UV, MS, NMR 
fusarins Fusarium moniliforme mutagenic [40] UV, MS 
LF594 enniatine various Fusarium sp. 
ionophore, 
insecticidal, ACAT 
inhibition, GABA 
receptor binding 
UV, MS 
Paecilomyces LF592 leucinostatins 
Paecilomyces lilacinus  
and other Paecilomyces sp. 
active against  
Gram-positive 
bacteria and fungi 
UV, MS 
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Table 2. Cont. 
Penicillium 
LF066 
compound C no hit in database  UV, MS, NMR 
meleagrin 
Penicillium 
meleagrinum and 
Penicillium 
chrysogenum 
structurally similar to 
tremorgenic mycotoxins 
UV, MS, NMR 
roquefortin C 
Penicillium roquefortii 
and other  
Penicillium sp. 
neurotoxin UV, MS, NMR 
sorbifuranones A–C 
Penicillium 
chrysogenum [31] 
 UV, MS, NMR 
2′,3′-dihydrosorbicillin 
Penicillium notatum, 
Verticillium intertextum 
weakly antibacterial [41] UV, MS 
bisvertonolone 
Penicillium 
chrysogenum, 
Verticillium intertextum, 
Acremonium strictum, 
Trichoderma 
longibrachiatum 
-1,6glucan biosynthesis 
inhibitor, antioxidative, 
inducer of hyphal 
malformation in fungi 
UV, MS
ergochromes 
Aspergillus ochraceus, 
Claviceps purpurea, 
Aspergillus aculeatus, 
Gliocladium sp., 
Penicillium oxalicum, 
Phoma terrestris, 
Pyrenochaeta terrestris 
teratogenic effects UV, MS 
LF259 mycophenolic acid 
Penicillium 
brevicompactum and 
other Penicillium sp. 
antineoplastig, antiviral 
immunosuppressant 
properties, useful in 
treating psoriasis and 
leishmaniasis,  
UV, MS 
LF590 
citreoviridins 
Penicillium citreoviride, 
Penicillium toxicarium, 
Penicillium 
ochrosalmoneum, 
Aspergillus terreus 
neurotoxic UV, MS, NMR 
territrem B 
Penicillium sp. and 
Aspergillus terreus 
inhibitor of 
acetylcholinesterase 
UV, MS 
LF607 
sclerotiorin 
Penicillium 
sclerotiorum and 
Penicillium multicolor 
inhibits cholesterin ester 
transfer protein activity 
UV, MS 
sclerotioramine   UV, MS, NMR 
compound D no hit in database  UV, MS, NMR 
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Table 2. Cont. 
Penicillium LF596 
griseofulvin 
Penicillium griseofulvum 
and other Penicillium sp. 
antifungal, possible 
human carcinogen 
UV, MS, NMR 
tryptoquivalin Aspergillus clavatus tremorgenic toxin UV, MS 
nortryptoquivalin 
Aspergillus clavatus and 
Aspergillus fumigatus 
tremorgenic toxin UV, MS 
fiscalins A and C Neosartorya fischeri 
substance P inhibitor, 
neurokinin binding 
inhibitor 
UV, MS, NMR 
Scopulariopsis LF580 scopularide A and B Scopulariopsis brevicaulis antiproliferative [25,26] UV, MS, NMR 
Clonostachys LF254 
T-988B Tilachlidium sp. cytotoxic UV, MS, NMR 
bionectin B Bionectria byssicola antibacterial (MRSA) UV, MS, NMR 
verticillin C Verticillium sp. antibiotic UV, MS 
a According to the Dictionary of Natural Products [42] if not stated otherwise; b blank cells indicate that no entry 
concerning bioactivity in the Dictionary of Natural Products was available and no report on bioactivity was found. 
For four compounds, database searches [33,42–43] did not lead to a hit (B, C, D) or no publication 
was available (A). The structure elucidations of compounds A and B, metabolites with modified 
diketopiperazine substructures, and compound D, a new azaphilone derivative, are in progress. 
Compound C was identified as the new metabolite cillifuranone and its structure is described in  
the following.  
Penicillium strain LF066, the producer of cillifuranone, was singled out for further investigations, 
because first surveys proved it to be a very potent producer of secondary metabolites. From the same 
strain, sorbifuranone B and C as well as 2′,3′-dihydrosorbicillin have already been described by 
Bringmann et al. [31] and it was obvious that the full potential of the strain had not been exploited, yet. 
Further analysis led to the detection of xanthocillines and sorbifuranones and the isolation of 
sorbifuranone B, meleagrin, roquefortin C, a couple of ergochromes as well as the new cillifuranone (1) 
whose structure was elucidated based on 1D and 2D NMR experiments. 
The 
13
C NMR spectrum of 1 displayed 10 clearly distinguishable carbon signals which was in good 
agreement with the molecular formula C10H12O4, deduced from the result of a HRESI-MS 
measurement (calculated for C10H12O4Na 219.0628, measured 219.0627). The carbon signals included 
resonances belonging to three carbonyl or enol carbons (δC 170.9, 196.7 and 201.7), three sp
3
 
hybridized methylene carbons (δC 20.9, 31.6 and 76.3), one methyl group (δC 14.0), two olefinic 
methines (δC 118.5 and 133.0) and finally one quaternary olefinic carbon (δC 112.6). The structure of 
the molecule could be delineated from 1D (
1
H, 
13
C and DEPT) and 2D NMR (
1
H-
13
C HSQC,  
1
H-
1
H COSY and 
1
H-
13
C HMBC) spectra. From the 
1
H-
1
H COSY spectrum two separate spin systems 
could be identified. The first one consisted of the olefinic methine groups CH-9 (δC 133.0, δH 7.32) and 
CH-10 (δC 118.5, δH 6.83), forming an E-configured double bond as proven by their 
3
J coupling 
constant of 16 Hz. The corresponding protons H-9 and H-10 both showed 
1
H-
13
C HMBC correlations 
to the carboxyl carbon C-11 (δC 170.9) as well as to the quarternary carbons of the furanone ring,  
C-3 (δC 201.7) to C-5 (δC 196.7). C-3 was the ketone carbonyl group included in the furanone 
substructure which was in accordance with its chemical shift. C-4 (δC 112.6) and C-5 were also part of 
the furanone and formed a tetrasubstituted double bond in which C-5 was located adjacent to an 
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oxygen atom. Compared to an unsubstituted enol, the resonance of C-5 was shifted further downfield 
due to the conjugation of the double bond Δ4,5 with the carbonyl carbon C-3. Apart from C-9 of the 
double bond Δ9,10, the carbonyl carbon C-3 and the oxygen atom of the furanone ring, Δ4,5 was also 
connected to C-6 of the second spin system consisting of the methylene groups CH2-6 (δC 31.6, 
δH 2.76) and CH2-7 (δC 20.9, δH 1.76) as well as the methyl-group CH3-8 (δC 14.0, δH 1.03). Thus, the 
second spin system evidently was an n-propyl-chain. The furanone ring was completed with the 
methylene group CH2-2 (δC 76.3, δH 4.67). Its 
1
H and 
13
C shifts proved it to be linked to an oxyen 
atom, the 
1
H-
13
C HMBC correlations to C-3 and C-5 secured its exact position. Thus, the structure of 
cillifuranone (1) could be unambiguously determined (Figure 3, Table 3). 
Figure 3. Spin systems deduced from the 
1
H-
1
H COSY spectrum (bold) and selected  
1
H-
13
C HBMC correlations (arrows) relevant to the structure elucidation of cillifuranone (1).  
 
Table 3. NMR spectroscopic data of cillifuranone (1) in methanol-d4 (500 MHz). 
Cillifuranone (1) 
Position δC, mult. δH, (J in Hz) COSY HMBC 
1     
2 76.3, CH2 4.67, s 6 3, 5, 6, 7 
3 201.7, C    
4 112.6, C    
5 196.7, C    
6 31.6, CH2 2.76, t (7.5) 2, 7 4, 5, 7, 8 
7 20.9, CH2 1.76, sext. (7.5) 6, 8 5, 6, 8 
8 14.0, CH3 1.03, t (7.5) 7 6, 7 
9 133.0, CH 7.32, d (16.0) 10 2, 3, 4, 5, 10, 11 
10 118.5, CH 6.83, d (16.0) 9 3, 4, 5, 9, 11 
11 170.9, C    
Cillifuranone (1) was tested in a panel of bioassays evaluating the compound with respect to 
cytotoxic, antimicrobial and enzyme inhibitory activity. Very low activity was only found against 
Xanthomonas campestris (24% growth inhibition) and Septoria tritici (20% growth inhibition) at a 
concentration of 100 µM. 
Strain LF066 was identified as Penicillium chrysogenum, a species that in our experience often 
produces metabolites deriving from sorbicillinol as a biosynthetic precursor (sorbicillinoids). The 
detection of bisvertinolone and the sorbifuranones in culture extracts of the fungus was consistent with 
this experience. Furanone substructures are abundant in natural products and can be found in 
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metabolites from bacteria, fungi and plants [42] and presumably are products from different 
biosynthetic pathways [44–46]. From the genus Penicillium a number of furanone containing 
compounds has been described, including simple small molecules like penicillic acid, but also more 
complex ring structures such as the rotiorinols [47] or rugulovasines [48]. In most cases the furanone 
ring is a furan-2(5H)-one, whereas in cillifuranone (1) we have a furan-3(2H)-one. With that 
differentiation being made the number of related compounds gets fewer, furan-3(2H)-ones do not seem 
to be as ubiquituous as the furan-2(5H)-ones. From Penicillium strains, apart from the above 
mentioned sorbifuranones, berkeleyamide D [49] and trachyspic acid [50], both spiro compounds like 
sorbifuranone C, are examples. The new cillifuranone represents a substructure of the sorbifuranones, 
albeit with a different configuration of the exocyclic double bond, and represents the substructure 
which makes the sorbifuranones unique in the compound class of the sorbicillinoids. Just recently 
Bringmann et al. [31] published the structures of the sorbifuranones and postulated 1 to be an 
intermediate in their biosynthesis (Figure 4) which makes the isolation of 1 a very interesting result. 
The only difference between the postulated intermediate and our structure is, as stated above, the 
configuration of the double bond. However, in the crude extract of the strain, we detected two isomers 
with the same molecular weight and a very similar UV-spectrum, so that we assume that both isomers 
were present, but after the isolation process only the E-isomer was obtained, so that it might be the 
favoured configuration under the applied conditions. 
Figure 4. Biosynthesis of sorbifuranone A via Michael reaction of an isomer of 
cillifuranone (1) and sorbicillinol as postulated by Bringmann et al. (modified from [31]). 
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3. Experimental Section 
3.1. Sampling Sites  
The Limsky kanal (Canal di Lemme or Limsky channel) is a semi-closed fjord-like bay in the 
Adriatic Sea nearby Rovinj (Istrian Peninsula, Croatia). It is situated along an east-west axis, with an 
approximate length of 1 km and a maximum width of about 650 m and reaches a maximum depth of 
32 m [51]. The sampling site was located at N45°7972′ and E13°43,734′. 
3.2. Sponge Collection 
Several specimens (13) of the Mediterranean sponge Tethya aurantium were collected by scuba 
diving. They were obtained in April 2003, June 2004, May 2005 and August 2006 in a depth of 5–15 m. 
The sponges were collected into sterile plastic bags, cooled on ice and transported immediately to the 
laboratory, where they were washed three times with sterile filtered seawater (0.2 µm). The sponge 
tissue was then cut into small pieces of approximately 0.1 cm
3
 each, which were either placed directly 
onto GPY agar plates (LF236 to LF255) or homogenized and diluted with membrane-filtered seawater 
(all other isolates). 
3.3. Isolation, Cultivation and Storage of Fungi 
Fungi were isolated on a low nutrient GPY agar, based on natural seawater of 30 PSU, containing 
0.1% glucose, 0.05% peptone, 0.01% yeast extract and 1.5% agar. Small pieces of sponge tissue or  
50 µL of the homogenate (undiluted or 1:10 or 1:100 diluted with sterile seawater) were used as 
inoculum. The agar plates were incubated for periods of 3 days to 4 weeks and were checked regularly 
for fungal colonies, which were then transferred to GPY agar plates. Pure cultures were used for 
morphological identification by light microscopy and for scanning electron microscopy. Fungal 
isolates were stored as agar slant cultures at 5 °C, and additionally were conserved at −80 °C using 
Cryobank vials (Mast Diagnostica). 
3.4. Morphological Identification of Fungal Isolates 
The morphology of GPY agar grown fungal isolates was studied using a stereo microscope  
(10–80× magnification) and a phase-contrast microscope (300–500× magnification). By this method, 
the majority of spore-producing isolates could be identified up to the generic level using the tables of 
Barnett and Hunter [52] and, for more detailed descriptions, the site of MycoBank [53]. Morphological 
identification of the selected pure cultures was supported by light microscopy and scanning  
electron microscopy. 
3.5. Scanning Electron Microscopy 
For electron microscopy, young GPY agar colonies were cut in 1 cm
2
 samples, transferred through 
an ethanol series (30, 50, 70, 90, 3 × 100%; each 15 min) and subsequently critical-point-dried in 
liquid carbon dioxide (Balzers CPD030). Samples were sputter-coated with gold-palladium (Balzers 
SCD004) and analyzed with a ZEISS DSM 940 scanning electron microscope. 
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3.6. Genetic Identification of Fungal Isolates and Phylogenetic Analysis 
DNA-extraction was performed using the Precellys 24 system (Bertin Technologies). To one vial of 
a Precellys grinding kit with a glass beads matrix (diameter 0.5 mm, peqlab Biotechnologies GmbH) 
400 µL DNAse-free water (Fluka) were added. Cell material from the fungal culture was then 
transferred to this vial and homogenized two times for 45 s at a shaker frequency of 6500. The 
suspension was centrifuged at 6000 g for 10 min and 15 °C. The supernatant was stored at −20 °C until 
further use in PCR.  
Fungal specific PCR by amplifying the ITS1-5.8S rRNA-ITS2 fragment was carried out using 
puReTaq™ Ready-To-Go™ PCR Beads (GE HEalthcare) with the ITS1 (5′-TCC GTA GGT GAA 
CCT GCG G-3′) and ITS4 (5′-TCC TCC GCT TAT TGA TAT GC-3′) primers according to  
White et al. [54]. PCR was conducted as follows: initial denaturation (2 min at 94 °C), 30 cycles of 
primer denaturation (40 s at 94 °C), annealing (40 s at 55 °C), and elongation (1 min at 72 °C) 
followed by a final elongation step (10 min at 72 °C). PCR products were checked for correct length 
(complete ITS1, 5.8S rRNA and ITS2 fragment length of Penicillium brevicompactum strain  
SCCM 10-I3 (EMBL-acc. No. EU587339 is 494 nucleotides), a 1% agarose gel in 1× TBE buffer  
(8.9 mM Tris, 8.9 mM borate, 0.2 mM EDTA).  
PCR products were sequenced using the ABI PRISM
®
 BigDye™ Terminator Ready Reaction Kit 
(Applied Biosystems) on an ABI PRISM
®
 310 Genetic Analyzer (Perkin Elmer Applied Biosystems). 
The ITS1 primer was used for sequencing. Sequence data were edited with ChromasPro Version 1.15 
(Technelysium Pty Ltd.). Sequences from fungal strains obtained during this study were submitted to 
the EMBL database and were assigned accession numbers (FR822769-FR822849). Closest relatives 
were identified by sequence comparison with the NCBI Genbank database using BLAST (Basic Local 
Alignment Search Tool) [55]. Sequences were aligned using the ClustalX version 2.0 software [56] 
and the alignment was refined manually using BioEdit (version 7.0.9.0) [57]. For alignment 
construction, ITS1-5.8S-ITS2 gene fragments from closest cultured relatives according to BLAST as 
well as type strains were used, whenever possible. However, not from all fungal species, ITS 
sequences from type strains were available in NCBI/Genbank. The ITS1-5.8S-ITS2 gene sequence of 
Saccharomyces boulardii strain UOA/HCPF EM10049 (acc. No. FJ433878) was used as outgroup 
sequence for phylogenetic calculations. Phylogenetic calculations were performed with all closest 
relatives according to BLAST results (data not shown). For clarity, not all of these sequences were 
included in Figure 2. Phylogeny was inferred using MrBayes version 3.1 [58,59], assuming the GTR 
(general time reversible) phylogenetic model with 6 substitution rate parameters, a gamma-shaped rate 
variation with a proportion of invariable sites and default priors of the program. 1,000,000 generations 
were calculated and sampled every 1000th generation. Burn-in frequency was set to 25% of the 
samples. The consensus tree was edited in Treeview 1.3 [60]. 
3.7. Fermentation and Production of Extracts 
The fungi were inoculated in 2 L Erlenmeyer flasks containing 750 mL modified  
Wickerham-medium [61], which consisted of 1% glucose, 0.5% peptone, 0.3% yeast extract,  
0.3% malt extract, 3% sodium chloride (pH = 6.8). After incubation for 11–20 days at 28 °C in the 
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dark as static cultures, extracts of the fungi were obtained. The mycelium was separated from the 
culture medium and extracted with ethanol (150 mL). The fermentation broth was extracted with ethyl 
acetate (400 mL). Both extracts were combined. Alternatively, cells and mycelium were not separated 
and the culture broth was extracted together with the cells of some cultures using ethyl acetate. After 
evaporation of the solvents, the powdery residue was reextracted with ethyl acetate (100 mL). The 
resulting residues were dissolved in 20 mL methanol and subjected to analytical HPLC-DAD-MS. 
3.8. Chemical Analysis 
UV-spectra of the identified metabolites were obtained on a NanoVue (GE Healthcare). NMR 
spectra were recorded on a Bruker DRX500 spectrometer (500 and 125 MHz for 
1
H and 
13
C NMR, 
respectively), using the signals of the residual solvent protons and the solvent carbons as internal 
references (δH 3.31 ppm and δC 49.0 ppm for methanol-d4). High-resolution mass spectra were 
acquired on a benchtop time-of-flight spectrometer (MicrOTOF, Bruker Daltonics) with positive 
electrospray ionization. Analytical reversed phase HPLC-DAD-MS experiments were performed using 
a C18 column (Phenomenex Onyx Monolithic C18, 100 × 3.00 mm) applying an H2O (A)/MeCN (B) 
gradient with 0.1% HCOOH added to both solvents (gradient: 0 min 5% B, 4 min 60% B, 6 min 
100% B; flow 2 mL/min) on a VWR Hitachi Elite LaChrom system coupled to an ESI-ion trap 
detector (Esquire 4000, Bruker Daltonics). 
Preparative HPLC was carried out using a VWR system consisting of a P110 pump, a P311 UV 
detector, a smartline 3900 autosampler and a Phenomenex Gemini-NX C18 110A, 100 × 50 mm, 
column or a Merck Hitachi system consisting of an L-7150 pump, an L-2200 autosampler and an  
L-2450 diode array detector and a Phenomenex Gemini C18 110A AXIA, 100 × 21.20 mm, column. 
For the preparation of cillifuranone (1), the same solvents were used as for the analytical HPLC, 
with a gradient from 10% B, increasing to 60% B in 17 min, to 100% B from 17 to 22 min. 1 eluted 
with a retention time of 6.8 min and the amount of 23.2 mg of 1 could be obtained from a culture 
volume of 10 L. 
Properties of cillifuranone (1): pale yellow needles; UV (MeOH) λmax (logε) 278 (4.36); for 1D and 
2D NMR data see Table 3 and SI; HRESIMS m/z 219.0627 (calcd for C10H12O4Na 219.0628). 
3.9. Bioassays 
Possible antimicrobial effects of cillifuranone (100 µM) were tested against Bacillus subtilis  
(DSM 347), Brevibacterium epidermidis (DSM 20660), Dermabacter hominis (DSM 7083),  
Erwinia amylovora (DSM 50901), Escherichia coli K12 (DSM 498), Pseudomonas fluorescens 
(NCIMB 10586), Propionibacterium acnes (DSM 1897
T
), Pseudomonas aeruginosa (DSM 50071), 
Pseudomonas syringae pv. aptata (DSM 50252), Staphylococcus epidermidis (DSM 20044), 
Staphylococcus lentus (DSM 6672), Xanthomonas campestris (DSM 2405), Candida albicans  
(DSM 1386), Phytophthora infestans, and Septoria tritici according to Schneemann et al. [62].  
In addition, cytotoxic activity of cillifuranone (50 µM) towards the human hepatocellular carcinoma 
cell line HepG2 and the human colon adenocarcinom cell line HT29 were performed according to  
Schneemann et al. [62]. Inhibitory activities of cillifuranone (10 µM) against the enzymes 
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acetylcholinesterase, phosphodiesterase (PDE-4B2), glycogen synthase kinase 3β, protein tyrosin 
phosphatase 1B, and HIV-1 reverse transcriptase were tested according to Helaly et al. [63]. 
4. Conclusion 
The marine sponge T. aurantium was found to be a valuable source of secondary metabolite 
producing fungi. In addition to a variety of known substances, several new natural products were found 
and it is likely that additional ones can be identified during further studies. The antiproliferative active 
scopularides [25,26] were the first new metabolites from a Scopulariopsis species isolated from  
T. aurantium. The new cillifuranone (1) is a second example of a natural product produced by a fungal 
isolate from T. aurantium. Additional compounds were detected of which the chemical structures are 
not yet described. The application of alternative cultivation methods, which have not been used so far, 
are expected to further increase the spectrum of produced metabolites of our isolates obtained  
from T. aurantium. 
The combination of morphological criteria and the results of the ITS1-5.8S-ITS2 fragment 
sequencing have been proven to be a valuable tool for the identification of fungal isolates. Apart from 
representatives of genera, which are widely distributed in terrestrial samples and in addition also 
reported from different sponges, we also identified members of taxa which so far have not been 
described to be associated with sponges. These strains distantly affiliated to Bartalinia sp. and 
Votutella sp. and one strain most likely is a new Phoma species.  
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